Cargando…
Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis
BACKGROUND: Epidemiological studies have reported conflicting findings on the potential adverse effects of long-term antihypertensive medication use on cancer risk. Naturally occurring variation in genes encoding antihypertensive drug targets can be used as proxies for these targets to examine the e...
Autores principales: | Yarmolinsky, James, Díez-Obrero, Virginia, Richardson, Tom G., Pigeyre, Marie, Sjaarda, Jennifer, Paré, Guillaume, Walker, Venexia M., Vincent, Emma E., Tan, Vanessa Y., Obón-Santacana, Mireia, Albanes, Demetrius, Hampe, Jochen, Gsur, Andrea, Hampel, Heather, Pai, Rish K., Jenkins, Mark, Gallinger, Steven, Casey, Graham, Zheng, Wei, Amos, Christopher I., Smith, George Davey, Martin, Richard M., Moreno, Victor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812899/ https://www.ncbi.nlm.nih.gov/pubmed/35113855 http://dx.doi.org/10.1371/journal.pmed.1003897 |
Ejemplares similares
-
Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis
por: Yarmolinsky, James, et al.
Publicado: (2023) -
Mendelian randomization applied to pharmaceutical use: the case of metformin and lung cancer
por: Yarmolinsky, James, et al.
Publicado: (2020) -
Identifying environmental risk factors for inflammatory bowel diseases: a Mendelian randomization study
por: Carreras-Torres, Robert, et al.
Publicado: (2020) -
Repurposing antihypertensive drugs for the prevention of Alzheimer’s disease: a Mendelian randomization study
por: Walker, Venexia M, et al.
Publicado: (2019) -
Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study
por: Fang, Si, et al.
Publicado: (2023)